Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
According to APO Research, The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for ICAD (Intracranial Atherosclerotic Disease) Pathology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for ICAD (Intracranial Atherosclerotic Disease) Pathology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for ICAD (Intracranial Atherosclerotic Disease) Pathology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology include Stryker, Balt, TERUMO, MicroPort and Acandis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ICAD (Intracranial Atherosclerotic Disease) Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ICAD (Intracranial Atherosclerotic Disease) Pathology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
According to APO Research, The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for ICAD (Intracranial Atherosclerotic Disease) Pathology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for ICAD (Intracranial Atherosclerotic Disease) Pathology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for ICAD (Intracranial Atherosclerotic Disease) Pathology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology include Stryker, Balt, TERUMO, MicroPort and Acandis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Stryker
- Balt
- TERUMO
- MicroPort
- Acandis
- Stent
- PTA Balloon
- Hospital
- Clinic
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ICAD (Intracranial Atherosclerotic Disease) Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ICAD (Intracranial Atherosclerotic Disease) Pathology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Estimates and Forecasts (2019-2030)
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Type
1.3.1 Stent
1.3.2 PTA Balloon
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Type (2019-2030)
1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size Review by Type (2019-2024)
1.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2024)
3.2 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2019-2024)
3.3 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2019-2024)
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Company Manufacturing Sites & Headquarters
3.6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company, Product Type & Application
3.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market CR5 and HHI
3.8.2 Global Top 5 and 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in 2023
3.8.3 2023 ICAD (Intracranial Atherosclerotic Disease) Pathology Tier 1, Tier 2, and Tier
4 ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY REGIONAL STATUS AND OUTLOOK
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Region
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2019-2024)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2019-2024)
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Region
4.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2025-2030)
4.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2025-2030)
4.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY BY APPLICATION
5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Application (2019-2030)
5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size Review by Application (2019-2024)
5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Stryker
6.1.1 Stryker Comapny Information
6.1.2 Stryker Business Overview
6.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.1.5 Stryker Recent Developments
6.2 Balt
6.2.1 Balt Comapny Information
6.2.2 Balt Business Overview
6.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.2.5 Balt Recent Developments
6.3 TERUMO
6.3.1 TERUMO Comapny Information
6.3.2 TERUMO Business Overview
6.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.3.5 TERUMO Recent Developments
6.4 MicroPort
6.4.1 MicroPort Comapny Information
6.4.2 MicroPort Business Overview
6.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.4.5 MicroPort Recent Developments
6.5 Acandis
6.5.1 Acandis Comapny Information
6.5.2 Acandis Business Overview
6.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.5.5 Acandis Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
7.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
7.1.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
7.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
7.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
7.2.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
8.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
8.1.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
8.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
8.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
8.2.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
9.1.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
9.1.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
9.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
9.2.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
10.1.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
10.1.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
10.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
10.2.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
10.2.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
11.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
11.1.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
11.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
11.2.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Analysis
12.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
12.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Estimates and Forecasts (2019-2030)
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Type
1.3.1 Stent
1.3.2 PTA Balloon
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Type (2019-2030)
1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size Review by Type (2019-2024)
1.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2024)
3.2 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2019-2024)
3.3 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2019-2024)
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Company Manufacturing Sites & Headquarters
3.6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company, Product Type & Application
3.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market CR5 and HHI
3.8.2 Global Top 5 and 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in 2023
3.8.3 2023 ICAD (Intracranial Atherosclerotic Disease) Pathology Tier 1, Tier 2, and Tier
4 ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY REGIONAL STATUS AND OUTLOOK
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Region
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2019-2024)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2019-2024)
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Region
4.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2025-2030)
4.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2025-2030)
4.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY BY APPLICATION
5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Application (2019-2030)
5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size Review by Application (2019-2024)
5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Stryker
6.1.1 Stryker Comapny Information
6.1.2 Stryker Business Overview
6.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.1.5 Stryker Recent Developments
6.2 Balt
6.2.1 Balt Comapny Information
6.2.2 Balt Business Overview
6.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.2.5 Balt Recent Developments
6.3 TERUMO
6.3.1 TERUMO Comapny Information
6.3.2 TERUMO Business Overview
6.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.3.5 TERUMO Recent Developments
6.4 MicroPort
6.4.1 MicroPort Comapny Information
6.4.2 MicroPort Business Overview
6.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.4.5 MicroPort Recent Developments
6.5 Acandis
6.5.1 Acandis Comapny Information
6.5.2 Acandis Business Overview
6.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.5.5 Acandis Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
7.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
7.1.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
7.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
7.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
7.2.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
8.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
8.1.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
8.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
8.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
8.2.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
9.1.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
9.1.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
9.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
9.2.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
10.1.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
10.1.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
10.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
10.2.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
10.2.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
11.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024)
11.1.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
11.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024)
11.2.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Analysis
12.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
12.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Stent
Table 2. Major Company of PTA Balloon
Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2019-2024)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2019-2024)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2019-2024) & (USD/Unit)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2025-2030) & (Units)
Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2025-2030)
Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2025-2030) & (US$ Million)
Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2025-2030)
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2025-2030) & (USD/Unit)
Table 14. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 15. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 17. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 19. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 21. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 23. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 24. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
Table 25. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
Table 26. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
Table 27. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2019-2024)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2019-2024) & (Units)
Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Company (2019-2024)
Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Price by Company (2019-2024) & (USD/Unit)
Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Company Manufacturing Sites & Headquarters
Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company, Product Type & Application
Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2019-2024) & (Units)
Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2019-2024)
Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2019-2024) & (US$ Million)
Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2019-2024)
Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2025-2030) & (Units)
Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2025-2030)
Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2025-2030) & (US$ Million)
Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2025-2030)
Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2025-2030)
Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2019-2024)
Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2019-2024)
Table 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2019-2024) & (USD/Unit)
Table 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2025-2030) & (Units)
Table 57. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2025-2030)
Table 58. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2025-2030) & (US$ Million)
Table 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2025-2030)
Table 60. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2025-2030) & (USD/Unit)
Table 61. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 62. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 64. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 66. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 68. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 70. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 71. Stryker Company Information
Table 72. Stryker Business Overview
Table 73. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 75. Stryker Recent Development
Table 76. Balt Company Information
Table 77. Balt Business Overview
Table 78. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 80. Balt Recent Development
Table 81. TERUMO Company Information
Table 82. TERUMO Business Overview
Table 83. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 85. TERUMO Recent Development
Table 86. MicroPort Company Information
Table 87. MicroPort Business Overview
Table 88. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 90. MicroPort Recent Development
Table 91. Acandis Company Information
Table 92. Acandis Business Overview
Table 93. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 95. Acandis Recent Development
Table 96. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 97. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 98. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 99. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 100. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 101. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 102. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 103. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 104. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 105. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 106. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 107. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 108. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 109. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 110. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 111. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 112. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 113. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 114. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 115. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 116. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 117. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 118. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 119. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 120. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 121. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 122. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 123. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 124. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 125. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 126. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 127. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 128. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 129. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 130. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 131. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 132. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 133. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 134. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 135. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 136. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 137. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 138. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 139. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 140. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 141. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 142. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 143. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 144. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 145. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 146. Key Raw Materials
Table 147. Raw Materials Key Suppliers
Table 148. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 149. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
Table 150. Research Programs/Design for This Report
Table 151. Authors List of This Report
Table 152. Secondary Sources
Table 153. Primary Sources
Table 1. Major Company of Stent
Table 2. Major Company of PTA Balloon
Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2019-2024)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2019-2024)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2019-2024) & (USD/Unit)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2025-2030) & (Units)
Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2025-2030)
Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2025-2030) & (US$ Million)
Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2025-2030)
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2025-2030) & (USD/Unit)
Table 14. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 15. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 17. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 19. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 21. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (Units)
Table 23. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024) & (US$ Million)
Table 24. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
Table 25. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
Table 26. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
Table 27. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2019-2024)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2019-2024) & (Units)
Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Company (2019-2024)
Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Price by Company (2019-2024) & (USD/Unit)
Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Company Manufacturing Sites & Headquarters
Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company, Product Type & Application
Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2019-2024) & (Units)
Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2019-2024)
Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2019-2024) & (US$ Million)
Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2019-2024)
Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2025-2030) & (Units)
Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2025-2030)
Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2025-2030) & (US$ Million)
Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2025-2030)
Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2025-2030)
Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2019-2024)
Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2019-2024)
Table 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2019-2024) & (USD/Unit)
Table 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2025-2030) & (Units)
Table 57. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2025-2030)
Table 58. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2025-2030) & (US$ Million)
Table 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2025-2030)
Table 60. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2025-2030) & (USD/Unit)
Table 61. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 62. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 64. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 66. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 68. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (Units)
Table 70. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024) & (US$ Million)
Table 71. Stryker Company Information
Table 72. Stryker Business Overview
Table 73. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 75. Stryker Recent Development
Table 76. Balt Company Information
Table 77. Balt Business Overview
Table 78. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 80. Balt Recent Development
Table 81. TERUMO Company Information
Table 82. TERUMO Business Overview
Table 83. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 85. TERUMO Recent Development
Table 86. MicroPort Company Information
Table 87. MicroPort Business Overview
Table 88. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 90. MicroPort Recent Development
Table 91. Acandis Company Information
Table 92. Acandis Business Overview
Table 93. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
Table 95. Acandis Recent Development
Table 96. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 97. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 98. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 99. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 100. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 101. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 102. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 103. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 104. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 105. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 106. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 107. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 108. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 109. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 110. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 111. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 112. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 113. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 114. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 115. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 116. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 117. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 118. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 119. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 120. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 121. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 122. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 123. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 124. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 125. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 126. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 127. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 128. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 129. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 130. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 131. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 132. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 133. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 134. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 135. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 136. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (Units): 2019 VS 2023 VS 2030
Table 137. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2024) & (Units)
Table 138. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2019-2024)
Table 139. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2025-2030) & (Units)
Table 140. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Country (2025-2030)
Table 141. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 142. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2019-2024) & (US$ Million)
Table 143. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2019-2024)
Table 144. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 145. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Country (2025-2030)
Table 146. Key Raw Materials
Table 147. Raw Materials Key Suppliers
Table 148. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 149. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
Table 150. Research Programs/Design for This Report
Table 151. Authors List of This Report
Table 152. Secondary Sources
Table 153. Primary Sources
LIST OF FIGURES
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2019-2030) & (US$ Million)
Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2019-2030) & (Units)
Figure 5. Product Picture of Stent
Figure 6. Global Stent Sales YoY Growth (2019-2030) & (Units)
Figure 7. Product Picture of PTA Balloon
Figure 8. Global PTA Balloon Sales YoY Growth (2019-2030) & (Units)
Figure 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type 2023 VS 2030
Figure 11. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 12. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2023
Figure 13. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 14. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2023
Figure 17. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 18. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 202
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2019-2030) & (US$ Million)
Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2019-2030) & (Units)
Figure 5. Product Picture of Stent
Figure 6. Global Stent Sales YoY Growth (2019-2030) & (Units)
Figure 7. Product Picture of PTA Balloon
Figure 8. Global PTA Balloon Sales YoY Growth (2019-2030) & (Units)
Figure 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type 2023 VS 2030
Figure 11. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 12. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2023
Figure 13. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 14. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2023
Figure 17. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2023
Figure 18. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 202
